again (and forgive me maui) while it is in fact frustrating for many of us that the CEO would bother to give us a specific time frame for updates and not follow through, I remind everyone, that this very much means something could have changed, for better or worse. the startup world is a rush of opportunities and dissapointments. glass half full, the fact there's a delay here can signal many things from business development, perhaps gaining notice that ADDF/Gates would fund and we have to wait til Jun 30, delay in data gathering, delay in response from creditor lawyers. it could be anything.
(3)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links